retatrutide triple agonist weight loss trial ๐จ TRIUMPH-1 Phase 3 top-line results, much awaited and just announced โฌ๏ธ 28.3% at 80 weeks โฌ๏ธ 30.3% weight loss at 104 weeks among adults with baseline BMI >35 Retatrutide, an experimental drug currently
Description
Gastroenterol Hepatol (N Y)
The physiology of glucagonlike peptide 1
Whether you're already taking one or considering both, heres what to know about how they work, why theyre sometimes prescribed together, and how they compare
Blurred vision or eye fatigue
From there it typically includes baseline bloodwork, a clear discussion of realistic expectations, a slow titration approach to minimise side effects, and scheduled follow-ups to review progress and adjust
They test their levels, identify specific deficiencies, source targeted supplements at therapeutic doses, and adjust based on results
